Achillion Pharma (ACHN) Misses Q4 EPS by 1c

Achillion Pharma (NASDAQ: ACHN) reported Q4 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

GUIDANCE:

Achillion Pharma sees FY2018 EPS of ($0.58)-($0.55), versus the consensus of ($0.71).

For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Is Treasury selloff a major issue for stock market bulls?